BeiGene Ltd. (49B) — Financial Flexibility Index
BeiGene Ltd. (49B) has a Financial Flexibility Index of 0.07x as of March 2025. Free cash flow of €160.49 Million (operating CF €44.08 Million minus capex €116.41 Million) represents 0% of total liabilities (€2.34 Billion). Check BeiGene Ltd. (49B) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BeiGene Ltd. Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for BeiGene Ltd. across 9 annual periods. See 49B net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BeiGene Ltd. (2016–2024)
Year-by-year free cash flow to debt coverage for BeiGene Ltd.. For the full company profile including market capitalisation, see market cap of BeiGene Ltd..
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | €388.51 Million | €-140.63 Million | €2.59 Billion | ▲ +152.0% |
| 2023 | -0.29x | €-654.63 Million | €-1.25 Billion | €2.27 Billion | ▲ +50.8% |
| 2022 | -0.59x | €-1.17 Billion | €-1.50 Billion | €2.00 Billion | ▼ -36.1% |
| 2021 | -0.43x | €-1.04 Billion | €-1.30 Billion | €2.40 Billion | ▲ +36.0% |
| 2020 | -0.67x | €-1.17 Billion | €-1.28 Billion | €1.73 Billion | ▲ +35.4% |
| 2019 | -1.04x | €-660.66 Million | €-750.27 Million | €633.93 Million | ▼ -8.3% |
| 2018 | -0.96x | €-477.43 Million | €-547.72 Million | €496.04 Million | ▼ -689.7% |
| 2017 | 0.16x | €59.13 Million | €12.75 Million | €362.25 Million | ▲ +113.1% |
| 2016 | -1.25x | €-66.01 Million | €-89.51 Million | €52.91 Million | — |